Paxillin antibody
Quick Overview for Paxillin antibody (ABIN2148487)
Target
See all Paxillin (PXN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Purification
- Paxillin antibody was purified by immunoaffinity chromatography.
- 
                                            Immunogen
- Paxillin antibody was raised in Rabbit using the peptide sequence around aa 116~120 (H-V-Y-S-F) derived from Human Paxillin as the immunogen.
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- IHC: 1:50-1:100, WB: 1:500-1:1000
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handling Advice
- Avoid repeated freeze/thaw cycles
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
 
- 
                                            
- 
    - Paxillin (PXN)
- 
                                            Alternative Name
- Paxillin
- 
                                            Pathways
- MAPK Signaling, EGFR Signaling Pathway, Response to Growth Hormone Stimulus, Cell-Cell Junction Organization, Maintenance of Protein Location, CXCR4-mediated Signaling Events, Signaling Events mediated by VEGFR1 and VEGFR2, Signaling of Hepatocyte Growth Factor Receptor, VEGF Signaling
 Target
- 
                    
 
                                     
                                     
                                    